Knife River’s activist margin target is not yet a cash bridge

Summary: Starboard wants Knife River to reach at least 22% Adjusted EBITDA margins by FY2029 and evaluate strategic alternatives. Knife River says it will engage but has not adopted that target or announced a sale process. The operating gap is real: Q2 Adjusted EBITDA margin was 14.9%, and FY2026 guidance implies about 15.4% at midpoint. But at the latest available $54.58 after-hours reference, a one-year guide-based valuation map has a flat base and a 33% adverse case. Reject / no trade.

Opportunity Ranking

Rank	Candidate	Direction	Mispricing	Evidence Freshness	Catalyst Window	Positioning	10/5 Status	Tradeability	Main Rejection Risk
1	Knife River (KNF)	Long	Starboard’s margin-and-options proposal versus a cyclical, acquisition-financed business with 14.9% Q2 margin and 3.2x net leverage	Starboard and issuer statements Sep. 24; Q2 10-Q Aug. 4	Shareholder engagement, operating updates and eventual FY2029 progress; no board timetable disclosed	Public activist presence; its ownership percentage and market flows not verified	Reject: base -0.4%, adverse -32.8%, no positive base reward	NYSE common; only an after-hours reference is used and execution evidence is absent	Proposed margin expansion is unadopted, while recent quarter margin fell and net debt rose
2	Priority Technology Holdings (PRTH)	Long	$8.05 cash take-private offer versus a $7.78 Sep. 25 after-hours indication	Definitive merger filing Sep. 21	Expected H1 2027 close, subject to approval and other conditions	CEO-led buyer and equity commitment disclosed; current arbitrage positioning unknown	Reject: only 3.5% gross spread before carry versus a 25% break-to-unaffected-price loss	Nasdaq; current spread, depth and exit capacity not verified	Capped upside fails +10%; deal break has asymmetric downside
3	BlackBerry (BB)	Long	QNX design-win backlog versus near-40x FY2027 adjusted-basic EPS midpoint	Q2 release Sep. 24; separate same-day run screen	Q3 and FY2027 results	Price reaction observed; holder and derivative positioning unknown	Reject: prior run’s guide-based map had +0.9% base and -35.5% stress	NYSE common; not reconsidered as the selected thesis	Same-day separate research run already covers this issuer; its backlog is not current revenue

Selected opportunity: Knife River, for the clearest fresh disagreement between an activist’s quantified operating proposal and the issuer’s current disclosed results. It is not a qualifying long.

Why this one now: The Sep. 24 letter adds a measurable FY2029 target, but the price reaction cannot substitute for an operating bridge. The latest Q2 filing documents the starting margin, leverage and capital plan against which the proposal must be tested.

What should surprise the reader: A 22% margin on Knife River’s $3.5 billion FY2026 revenue midpoint would imply roughly $770 million of Adjusted EBITDA, about 43% above the $540 million FY2026 guidance midpoint. That is a useful scale check, not Starboard’s forecast for FY2026 or company guidance.

Why This Is the Best Opportunity Right Now

KNF offers a potentially consequential catalyst, but the proposal leaves the bridge incomplete. Starboard calls for cost reductions, improved aggregate pricing and strategic alternatives; management already says its EDGE program targets pricing and operating efficiency. The new information is an outside shareholder’s deadline and pressure, not yet evidence that the company has changed its plan, that the board has begun a sale, or that margins are already improving.

PRTH is a different event-driven setup, but its contractual cash consideration caps gross upside below the Desk’s base-case hurdle at the latest reference. BB is a separate run’s deeper operating screen and is included only as a comparison, not recycled as this article’s thesis.

Why This Can Move More Than 5% Soon

The margin proposal could re-rate KNF if the board adopts an actionable plan or begins a strategic process. A 22% margin on unchanged FY2026 midpoint revenue of $3.5 billion would imply $770 million EBITDA versus $540 million guided for FY2026. That rough comparison ignores future revenue growth, acquisitions, mix and timing; it does not establish the value of a sale or the probability of reaching the target.

The cheapest falsification test is the next reported quarter: compare Adjusted EBITDA margin, aggregate price/volume, contracting backlog margin and net debt with the Q2 baseline. The company’s Sep. 24 statement announced engagement but no specific timetable, agreement or transaction. Its Q2 report said expected backlog margins were slightly lower year over year, a fact that weakens any assumption of immediate margin recovery.

10/5 Asymmetry Gate

Reject / no trade. The scenario map uses $54.58, the latest observed feed reference at 7:15 p.m. EDT on Sep. 25; it is not represented as an independently verified regular-session close. On a 12-month horizon, the highest-probability base value is $54.34 (-0.4%); the adverse value is $36.65 (-32.9%). There is no positive base-case reward, the reward/adverse ratio is 0:1, and expected reference value is $53.29 (-2.4%) before costs. These are valuation sensitivities, not price bounds. The Desk’s long 10/5 test fails decisively.

What Should Surprise the Reader

The activist’s 22% objective is not obviously a near-term forecast. Applied mechanically to a flat $3.5 billion revenue base, it produces $770 million EBITDA. That is $230 million above the company’s FY2026 midpoint guide and requires material improvement beyond the current operating level. This arithmetic gives the target scale; it does not validate the assumptions required to reach it.

The business has real strategic assets: Knife River reported 1.3 billion tons of aggregate reserves in its 2025 Form 10-K and operates an integrated materials and contracting network. Those assets can support pricing and reduce local competition. But asset scarcity is not the same as realizable sale value, and a strategic alternative is not a signed bid.

The Setup

Knife River supplies aggregates, ready-mix concrete, asphalt and contracting services across 15 states. In Q2 2026, revenue rose 13% to $938.6 million, while net income fell 13% to $43.9 million. Adjusted EBITDA was $139.7 million, down 1%; divided by revenue, that is a 14.9% margin versus 16.9% a year earlier. Management attributed pressure to energy costs, delayed-impact projects and contracting mix/timing, plus a $10.3 million prior-year asset-sale gain compared with $0.65 million this quarter. These explanations may be temporary, but the reported margin decline remains the starting fact.

FY2026 guidance is $3.4-$3.6 billion revenue and $520-$560 million Adjusted EBITDA. Midpoints are $3.5 billion and $540 million, a 15.4% margin. The company reported $40.7 million unrestricted cash, $1.600 billion long-term debt and 3.2x net leverage at June 30. The 10-Q reports 56.763 million shares outstanding. The company expects another $76.4 million of organic growth-project spending in the second half; future acquisition capex is incremental and may be funded with operating cash and debt. A margin program therefore competes with capital allocation and balance-sheet repair.

The Market Price

The pricing reference is $54.58 at 7:15 p.m. EDT on September 25, 2026 from a finance-feed snapshot, after the regular session. StockAnalysis shows the latest regular-session close I could independently verify as $53.37 at 4:00 p.m. EDT on September 24. A separate historical-data page lists $54.58 for September 25 but also shows a later after-hours last trade; because the session label is ambiguous, the article uses $54.58 only as an explicitly after-hours reference, never as an executable entry. It is 2.3% above the prior verified close, but that move says nothing by itself about holder flows or the durability of the activist catalyst.

At $54.58 and 56.763 million shares, implied equity value is about $3.10 billion. Adding $1.600 billion debt and subtracting $40.7 million unrestricted cash gives an estimated enterprise value of about $4.66 billion, or 8.6x the $540 million FY2026 Adjusted EBITDA midpoint. This simplified bridge excludes other claims and assumes the Q2 share count; it is not a full valuation.

The Mispricing

The bull case says investors underprice Knife River’s local aggregate reserves, vertical integration and potential operating leverage. Starboard adds pressure for a 22% FY2029 margin and asks the board to evaluate strategic alternatives. Management’s response commits to engagement and restates its existing EDGE priorities; it does not endorse the target or announce a review process.

The market could be underestimating the value of operational improvements or strategic scarcity. It could also be correctly discounting execution risk: Q2 margin contracted, backlog margin was slightly lower year over year, and net leverage reached 3.2x. The reviewed sources do not establish activist ownership size, total current holders, short interest, borrow, options exposure or fund flows. Positioning is therefore largely unknown, not “crowded short.”

The Positioning

Starboard identifies itself as a Knife River stockholder and publicly advocates change. The available release does not quantify its stake, and I did not verify a current ownership filing or full holder base in this run. The presence of an activist can attract event-driven buyers, but no direct evidence shows forced covering, dealer hedging, or a durable supply-demand imbalance. The 2.3% change to the after-hours feed reference is price behavior, not positioning data.

The Catalyst

Shareholder engagement: Knife River says it will engage with Starboard. The test is whether a subsequent company or filing disclosure identifies a measurable operating plan, board action or timetable.
Next quarterly results: date not confirmed in the reviewed company calendar. Test pricing, volume, Adjusted EBITDA margin, backlog margin, leverage and cash funding against the Q2 baseline.
FY2029 margin objective: Starboard’s target is due by FY2029, but no interim milestones or company adoption were identified in its public release. Any progress should be tested against reported margins, not the target headline.
Strategic alternatives: the board has not announced a sale process. A process, bids and financing certainty would be new evidence; speculation about a buyer is not.

The Payoff

For a 12-month sensitivity, I hold FY2026 guide midpoint EBITDA of $540 million as the base operating anchor and use 8.6x EV/EBITDA, near the current simplified implied multiple. The top case applies the high guide of $560 million at 10x; the bottom applies the low guide of $520 million at 7x. I subtract estimated net debt of $1.559 billion and divide by 56.763 million shares. The multiples and probabilities below are analyst assumptions, not observed frequencies. No transaction premium is assumed because no sale process exists.

Price Target and Probability Map

Scenario	Probability	Target / Level	Return / Payoff	Horizon	Conditions	Evidence Quality
Top Case	20%	$71.18	+30.4%	12 months	High guide EBITDA; 10x multiple as operating and activist pressure earns a re-rating	Low
Base Case	55%	$54.34	-0.4%	12 months	Midpoint guide; 8.6x multiple; no demonstrated sale or accelerated margin plan	Medium for guide, low for multiple
Bottom Case	25%	$36.65	-32.9%	12 months	Low guide EBITDA; 7x multiple for cyclical execution and leverage risk	Low
Invalidation	n/a	No credible $770M-plus EBITDA bridge by FY2029, or net leverage rises materially	Rebuild the thesis; no automatic trade action	On new filing or board disclosure	Measure actual margin, cash generation, debt and any adopted plan	Medium

Probability-weighted expected value: $53.29, or -2.4% versus the $54.58 after-hours reference, before costs. Current market level and timestamp: $54.58, Sep. 25, 2026, 7:15 p.m. EDT (after-hours feed reference); last separately verified regular close was $53.37 on Sep. 24. Primary instrument: None; research-only comparison is unlevered NYSE common stock. 10/5 favorable base move: -0.4%. 10/5 credible adverse move: -32.9% modeled stress; downside is not capped. 10/5 measurement basis: reference-only. 10/5 status: Reject. Confidence: Low; no board decision, sale process, execution snapshot or validated path to 22% is available.

The weighted value is 0.20×$71.18 + 0.55×$54.34 + 0.25×$36.65 = $53.29. A 10% base return would require an equity value of $60.04 per share. With the base EBITDA assumption and estimated net debt, that corresponds to roughly 9.2x EV/EBITDA, but even that sensitivity would leave the 32.9% bottom case far outside the adverse-risk limit.

The Kill Shot

The strongest bull counterargument is that management already has an EDGE program targeting pricing and efficiency, while Starboard can add urgency and the company controls scarce local aggregate reserves. Public infrastructure demand, contracting backlog and acquisition contributions could lift both revenue and utilization; the Q2 explanation includes timing and a prior-period asset-sale comparison.

That case does not rescue the trade. The load-bearing assumption is that the board converts an outside target into a credible, funded, measurable operating plan quickly enough to justify a higher multiple. The available evidence shows engagement only. Even if margins improve directionally, commodity costs, weather, project timing, debt-funded growth and multiple compression can overwhelm per-share returns. The 10/5 rejection holds.

What Could Go Wrong

Aggregate prices or volumes weaken, or energy, labor, weather and project timing keep margins below the guide.
Backlog conversion produces revenue but not the expected margin; Q2 backlog margins were slightly lower year over year.
Debt-funded acquisition and growth spending increases interest cost before returns mature.
Starboard’s proposal is delayed, narrowed or rejected; no sale process or buyer is announced.
A sale process, if started, fails to produce an offer above standalone value or faces financing, regulatory or shareholder obstacles.
Reference data are session-ambiguous, and spreads, depth, venue quality, volume quality and exit liquidity are not measured here. Gap, halt and slippage risk can exceed modeled moves.

What Would Prove This Wrong

The Reject classification would be too conservative if Knife River reports sustained margin expansion with lower net leverage, publishes interim milestones that credibly bridge toward 22% by FY2029, and the board discloses a funded plan or value-maximizing process. A fresh model would still need a regular-session quote and evidence that a base case clears +10% while credible downside is within -5% and gross reward/risk exceeds 2:1.

Risk Audit

The scenario bottom is a multiple-and-guidance stress, not a worst case. A recession, acquisition impairment, contract loss, financing pressure, dilution, regulatory issue or failed project could produce a larger loss. The 3.2x reported net leverage and continuing growth capex constrain flexibility. No stop is assumed to cap a gap, and no live execution or exit-capacity test was conducted.

Best Trade Strategy

No trade. Keep entry.price=null and execution.can_execute=false. The $54.58 mark is after-hours reference context, while $53.37 is the last separately verified regular close available in the reviewed historical feed. Reassess only after a fresh regular close and new operating or board evidence; require a current spread, depth, venue, volume-quality and exit-liquidity check before considering ordinary common shares. No options, leverage, margin, market orders or price-floor logic.

Sources

Knife River Q2 2026 results, SEC Exhibit 99.1, issuer release, Aug. 4; revenue, Adjusted EBITDA, guide, capex, cash, debt and leverage.
Knife River Q2 2026 Form 10-Q, issuer filing, Aug. 4; shares outstanding, debt, backlog and risk discussion.
Starboard’s Sep. 24 letter announcement, investor-authored release; its FY2029 22% Adjusted EBITDA margin target and request to evaluate strategic alternatives. The distributor page did not render in the source viewer; the release text was cross-checked against Yahoo Finance’s Business Wire republication and Fidelity’s Business Wire republication. The full underlying letter was not separately reviewed.
Knife River’s Sep. 24 response, issuer statement; it will engage with Starboard and reiterates its EDGE strategy. The distributor page did not render; the issuer statement was cross-checked against MarketMinute’s Business Wire republication.
KNF Sep. 25 quote snapshot, secondary data; $54.58 at 7:15 p.m. EDT (after-hours reference), not a verified regular close.
KNF historical price table, secondary data; Sep. 24 regular close $53.37 at 4:00 p.m. EDT.
Priority Technology merger announcement, SEC Exhibit 99.1, Sep. 21; $8.05 consideration, 38% premium to Sep. 18 close, expected H1 2027 completion, no financing condition.
PRTH Sep. 25 quote, after-hours reference only; compared with $8.05 consideration.
BlackBerry Q2 FY2027 results, SEC Exhibit 99.1, candidate comparison and separate run article.

Research Quality Scorecard

Criterion	Score	Evidence and deduction
Market disagreement	4/5	Specific activist target versus current results, but not yet a market-implied scenario bridge
Evidence base	4/5	Fresh issuer response and audited filing data; Starboard’s full underlying letter was not separately reviewed
Positioning and flows	2/5	Activist presence known; stake size, holder base, borrow, options and fund flows unverified
Catalyst path	3/5	Engagement and future filings observable; no timetable or adopted milestones
Payoff architecture	2/5	Explicit guide-based cases fail 10/5 and are reference-only
Invalidation discipline	4/5	Margin, backlog, debt and board disclosures are monitorable
Differentiated insight	4/5	Translates the 22% target into a scale test and separates engagement from a sale process
Client value	4/5	Shows why an activist catalyst does not itself establish an asymmetric long
Total	27/40	No-trade screen; economics require Reject despite Watchlist-range score

Bottom Line

Starboard’s target creates a measurable operating test, not a completed catalyst. Knife River’s FY2026 midpoint implies roughly 15.4% EBITDA margin, while Q2 posted 14.9%; achieving 22% on flat midpoint revenue would imply about $770 million EBITDA. The company has not adopted that target or announced strategic alternatives. At the latest available after-hours reference, the 12-month base is flat and modeled downside is about 33%. Reject / no trade.

AI Illustration Prompt

Create a sober editorial finance illustration for The Mispricing Desk: a quarry conveyor carrying aggregate beside a margin bridge labeled “KNF Q2 14.9% → STARBOARD FY2029 22% PROPOSAL,” with the bridge unfinished and a gap marked “NO ADOPTED PLAN / NO SALE PROCESS.” Add a balance-sheet panel “FY2026 EBITDA GUIDE $520M–$560M / NET LEVERAGE 3.2x,” a price strip “SEP 24 REGULAR CLOSE $53.37 / SEP 25 AFTER-HOURS REFERENCE $54.58,” and scenario branches “TOP $71.18 / BASE $54.34 / BOTTOM $36.65.” Clearly distinguish issuer guidance, activist proposal and analyst sensitivity. Use warm paper, graphite, muted slate and restrained amber; no generic candlesticks, invented logos or profit promises. Add a subtle readable “The Mispricing Desk” watermark in a wide 16:9 editorial composition.